Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary

Annals of Oncology

Volumn 25, Issue 1, 2014, Pages 166-171

  Uzan, C ^a,f   Muller, E ^a   Kane, A ^a   Rey, A ^c   Gouy, S ^a   Bendiffallah, S ^d   Duvillard, P ^e   Fauvet, R ^f   Darai, E ^d   Morice, P ^a,b,g  

^a Gustave Roussy   (France)

^b INSERM   (France)

^c Gustave Roussy   (France)

^d HÔPITAL TENON   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f AMIENS UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Borderline tumor; Conservative treatment; Follow up; Ovary; Recurrence; Serous tumor

Indexed keywords

ADNEXECTOMY; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CYSTECTOMY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GYNECOLOGIC SURGERY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARIAN PRESERVATION; OVARY TUMOR; PERITONEAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEROUS BORDERLINE OVARIAN TUMOR; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR INVASION; TUMOR RECURRENCE;

BORDERLINE TUMOR; CONSERVATIVE TREATMENT; FOLLOW-UP; OVARY; RECURRENCE; SEROUS TUMOR;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 84902576026     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt430     Document Type: Article

References (19)

1. Daraï E, Fauvet R, Uzan C et al. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update 2013; 19: 151-166.
2. Koskas M, Uzan C, Gouy S et al. Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol 2011; 18: 40-48.
3. Khunamornpong S, Settakorn J, Sukpan K et al. Mucinous tumor of low malignant potential ("borderline" or "atypical proliferative" tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion. Int J Gynecol Pathol 2011; 30: 218-230.
4. Fauvet R, Demblocque E, Morice P et al. Comparison of epidemiological factors between serous and mucinous borderline ovarian tumors: therapeutic implications. Bull Cancer 2012; 99: 551-556.
5. Burks R, Sherman M, Kurman R. Micropapillary serous carcinoma of the ovary: a distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20: 1319-1330.
6. Song T, Lee YY, Choi CH et al. Histologic distribution of borderline ovarian tumors worldwide: a systematic review. J Gynecol Oncol 2013; 24: 44-51.
7. Morice P, Uzan C, Fauvet R et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol 2012; 13: e103-e115.
8. Wong HF, Low JJ, Chua Y et al. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer 2007; 17: 342-349.
9. Song T, Hun Choi C, Lee YY et al. Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours. Hum Reprod 2011; 26: 2008-2014.
10. Park JY, Kim DY, Kim JH et al. Surgical management of borderline ovarian tumors: the role of fertility-sparing surgery. Gynecol Oncol 2009; 113: 75-82.
11. Fauvet R, Poncelet C, Boccara J et al. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril 2005; 83: 284-290. quiz 525-586.
12. Du Bois A, Ewald-Riegler N, de Gregorio N et al. Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. Eur J Cancer 2013; 49: 1905-1914.
13. Uzan C, Kane A, Rey A et al. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol 2010; 21: 55-60.
14. Tavassoli FA, Devilee P. World Health Organization. Classification of the Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Lyon: IARC Press 2003.
15. International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987; 156: 263-264.
16. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer 1988; 62: 2212-2222.
17. Zanetta G, Rota S, Chiari S et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001; 19: 2656-2664.
18. Trimble CL, Kosary C, Trimble EL. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol. 2002; 86: 34-37.
19. Palomba S, Falbo A, Del Negro S et al. Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up. Hum Reprod 2010; 25: 1966-1972.